Phio Pharmaceuticals Corp.

11 Apex Drive Suite 300 A
PMB 2006
Marlborough, MA
United States 01753

Phio Pharmaceuticals is a clinical-stage siRNA biotechnology company advancing its INTASYL gene silencing technology focused on immuno-oncology therapeutics. Phio's INTASYL compounds are designed to enhance the body's immune cells to more effectively kill cancer cells.

Recent News